Status:
UNKNOWN
Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This single-center, randomized controlled trial is to investigate the impact of remote ischemic preconditioning (RIPC) on the risk contrast-induced acute kidney injury and its long-term impact on rena...
Detailed Description
Patients with diabetes undergoing elective percutaneous coronary intervention in Beijing Anzhen Hospital were enrolled, and all the eligible participants were randomized to either remote ischemic prec...
Eligibility Criteria
Inclusion
- Patients with diabetes undergoing percutaneous coronary intervention were included.
Exclusion
- emergency PCI,
- baseline troponin value \> 0.04 ng/mL,
- nicorandil or glibenclamide use (preconditioning-mimetic and preconditioning-blocking medication, respectively),
- patient on dialysis,
- patients who had some inability to cooperate with the trial,
- those who could not give informed consent, and (7) second procedure of staged elective PCI in this hospitalization.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT01827891
Start Date
March 1 2012
End Date
June 1 2013
Last Update
April 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital, Capital Medical University
Beijing, China, 100029